Off label use of lithium in the treatment of Huntington′s disease: A case series
Authors:
Open Access
- 1 January 2013
- journal article
- case report
- Published by Medknow in Indian Journal of Psychiatry
- Vol. 55 (1) , 81-3
Abstract
Huntington's disease is characterized by choreic movements, psychiatric disorders, striatal atrophy with selective small neuronal loss, and autosomal dominant inheritance. The genetic abnormality is CAG expansion in Huntingtin gene. Newer therapeutic strategies are evolving to treat this progressive disorder. The neuroprotective agents are one such group of drugs being tried. Lithium has been used to treat Huntington's disease in the past due to its neuroprotective effects. Though the precise mechanism of action is not clear, Lithium can directly or indirectly modulate proteins involved in neuronal survival/differentiation which may account for its neuroprotective effects. We report three patients with Huntington's disease in whom Lithium prevented the progression of chorea and also helped stabilize mood.Keywords
This publication has 16 references indexed in Scilit:
- The Mood Stabilizers Valproic Acid and Lithium Enhance Mesenchymal Stem Cell Migration via Distinct MechanismsNeuropsychopharmacology, 2010
- Potential Mechanisms Involved in the Prevention of Neurodegenerative Diseases by LithiumCNS Neuroscience & Therapeutics, 2009
- Review of Lithium Effects on Brain and BloodCell Transplantation, 2009
- The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisBipolar Disorders, 2009
- Lithium and Neuropsychiatric Therapeutics: Neuroplasticity via Glycogen Synthase Kinase-3β, β-Catenin, and Neurotrophin CascadesJournal of Pharmacological Sciences, 2009
- Glucocorticoids and Lithium Reciprocally Regulate the Proliferation of Adult Dentate Gyrus-Derived Neural Precursor Cells Through GSK-3β and β-Catenin/TCF PathwayNeuropsychopharmacology, 2008
- Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activationMolecular Psychiatry, 2007
- Therapeutic Strategies in Huntington's DiseaseJournal of Clinical Neurology, 2006
- The Antiapoptotic Actions of Mood Stabilizers: Molecular Mechanisms and Therapeutic PotentialsAnnals of the New York Academy of Sciences, 2005
- Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomesTrends in Pharmacological Sciences, 2003